Elucidating the exact pharmacological mechanism of motion (MOA) of The natural way taking place compounds is often challenging. Although Tarselli et al. (60) designed the initial de novo synthetic pathway to conolidine and showcased that this Normally developing compound correctly suppresses responses to equally chemically induced and inflammation-